EW
51
-2
SJM
12
-2
EQR
39
-3
DIS
62
-2
NKE
34
-2
DLTR
62
-2
SWK
56
-2
PNC
75
3
LLY
60
-2
BIIB
50
-2
DOV
69
-2
UNM
52
2
MCK
60
-2
MMM
59
2
JPM
60
-9
T
30
-2
NWSA
66
4
DVN
44
-3
FRT
53
3
JNJ
51
-3
EW
51
-2
SJM
12
-2
EQR
39
-3
DIS
62
-2
NKE
34
-2
DLTR
62
-2
SWK
56
-2
PNC
75
3
LLY
60
-2
BIIB
50
-2
DOV
69
-2
UNM
52
2
MCK
60
-2
MMM
59
2
JPM
60
-9
T
30
-2
NWSA
66
4
DVN
44
-3
FRT
53
3
JNJ
51
-3
Financhill
Back

Blackbaud, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
63

BLKB
Blackbaud, Inc.

Last Price:
$62.38
Seasonality Move:
-1.02%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
63
Blackbaud, Inc. (BLKB) is a Buy

Is Blackbaud, Inc. a Buy, Sell or Hold?

  • The current Blackbaud, Inc. [BLKB] share price is $61.36. The Score for BLKB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • BLKB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

BLKB Stock Price Chart

What is Blackbaud, Inc.'s stock price today?

  • The Blackbaud, Inc. share price today is $61.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLKB is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

BLKB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 53.72 Buy
Chaikin Money Flow: -73528 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.58 - 61.28) Buy
Bollinger Bands (100): (60.16 - 67.06) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

BLKB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.61 Buy
20-day SMA: 58.93 Buy
50-day SMA: 61.48 Sell
200-day SMA: 63.43 Sell
8-day EMA: 60.79 Buy
20-day EMA: 60.02 Buy
50-day EMA: 61.22 Buy
200-day EMA: 65.13 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Blackbaud, Inc. Earnings Growth & BLKB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.52 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Blackbaud, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):